FACTORS ASSOCIATED WITH CHRONIC PAIN CHARACTERISTICS ASSESSED USING THE McGILL PAIN QUESTIONNAIRE IN MAINTENANCE HEMODIALYSIS PATIENTS AT MILITARY HOSPITAL 103

Pham Quoc Toan1, , Hoang Trung Vinh1, Nguyen Van Tu2, Nguyen Thi Thu Ha1
1 Military Hospital 103, Vietnam Military Medical University
2 Vietnam Military Medical University

Nội dung chính của bài viết

Tóm tắt

Objectives: To evaluate the association between chronic pain characteristics assessed using the McGill Pain Questionnaire and selected clinical and laboratory parameters in maintenance hemodialysis (MHD) patients. Methods: A cross-sectional descriptive study was conducted on 131 patients with end-stage renal disease (ESRD) undergoing MHD at Military Hospital 103 from May 2024 to May 2025. Results: Chronic pain was highly prevalent among MHD patients, with a rate of 83.97%. Sex significantly influenced the total sensory-affective pain rating index (PRI-T), with higher scores observed in female patients (p = 0.02). Duration of hemodialysis was strongly associated with pain severity (p = 0.002), with total pain scores increasing with longer dialysis duration, particularly in patients undergoing MHD for more than 7 years. Longer duration of chronic pain was associated with higher total pain scores (p = 0.019). Age at pain onset also affected pain intensity, with patients experiencing pain onset at an older age more likely to report moderate to severe pain (p = 0.037). Conclusion: Chronic pain is highly prevalent in MHD patients and is associated with sex, hemodialysis duration, chronic pain duration, and age at pain onset. The McGill Pain Questionnaire is a useful tool for assessing pain severity and characteristics in this population.

Chi tiết bài viết

Tài liệu tham khảo

1. Srinivasa N Raja, Daniel B Carr, Milton Cohen, et al. The Revised IASP definition of pain: Concepts, challenges, and compromises. The IASP Council in 1979. 2020; 161(9):1976-1982
2. International Association for the Study of Pain. IASP revises its definition of pain for the first time since 1979. IASP. 2020.
3. Mercadante S, Ferrantelli A, Tortorici C, et al. Incidence of chronic pain in patients with end-stage renal disease on dialysis. J Pain Symptom Manage [Internet]. 2005 October; 30(4):302.
4. Davison SN. Clinical pharmacology considerations in pain management in patients with advanced kidney failure. Clin J Am Soc Nephrol [Internet]. 2019; 14(6):917-931.
5. Sadigova E, Ozkurt S, Yalcin A. Pain assessment in hemodialysis patients. Cureus. 2020; 12(2):e6903. DOI: 10.7759/ cureus.6903.
6. Lambourg E, Colvin L, Guthrie G, Murugan K, Lim M, Walker H, Boon G & Bell S. The prevalence of pain among patients with chronic kidney disease using systematic review and meta-analysis. Kidney International. 2021; 100(3):636-649.
7. Levey AS, Coresh J, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003; 139(2):137-147.
8. Anna Masajtis-Zagajewska, Michal Nowicki. Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease - a randomized double-blind crossover study. Renal Failure. 2018; 40;1:701-771.